It's finally becoming a bit clearer why Donald Trump appears so fixated with the malaria, lupus and rheumatoid arthritis drug hydroxychloroquine as a potential miracle drug against COVID-19, despite its horrendous side-effects (nausea, paranoia and hallucinations, blindness, hair loss, kidney failure, heart arrhythmia, cardiac arrest) and the sparse, anecdotal-at-best evidence that it can actually be effective.
It turns out, and why am I not surprised, that Trump, and various other close associates and major donors, have a financial interest in Sanofi, the French pharmaceutical company that manufactures the drug under the brand-name Plaquenil.
Meanwhile, some sufferers from lupus and rheumatoid arthritis are finding the only drug they can take to relieve their symptoms becoming more and more scarce, especially given that the US government has been stockpiling an estimated 29 million doses of hydroxychloroquine based on little more than an unproven hunch of Donald Trump ("What do I know? I'm not a doctor.")
No comments:
Post a Comment